Not Yet Recruiting PHASE3 INTERVENTIONAL 2-arm
NCT06727734
Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception
Levonorgestrel-piroxicam Combination Versus Ulipristal Acetate for Emergency Contraception: a Randomised Double-blind Controlled Trial
Sponsor: The Family Planning Association of Hong Kong
Conditions
Contraception
Interventions
Levonorgestrel Piroxicam Placebo - LNG Placebo - Piroxicam Placebo - UPA Ulipristal Acetate
Updated 1 time since 2025 Last updated: Dec 23, 2024 Started: Dec 31, 2024 Primary completion: Sep 30, 2027 Completion: Oct 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE3 trial investigates Contraception and is currently actively recruiting participants. The Family Planning Association of Hong Kong leads this study, which shows 1 recorded version since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- The Family Planning Association of Hong Kong
- The University of Hong Kong
Data source: The University of Hong Kong
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.